2021 annual financial data
Innate Pharma 2021 Operating cash flow margin
Innate Pharma 2021 operating cash flow margin with verified reported values.
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -47,825,000 EUR and net income was -52,809,000 EUR.
Operating cash flow was Not available.
Get free Innate Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,112,000 EUR
- Operating income
- -47,825,000 EUR
- Net income
- -52,809,000 EUR
- Operating cash flow
- Not available